newsfilter
← Latest News
ACCESS Newswire·

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference

TORONTO, ON / ACCESSWIRE / March 21, 2024 / Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today